• With: Ann Romney

    This is a rush transcript from "Your World," October 15, 2014. This copy may not be in its final form and may be updated.

    (BEGIN VIDEO CLIP)

    MITT ROMNEY, R-FORMER PRESIDENTIAL CANDIDATE: Fame, as they say in the song, comes and goes in a minute. You're lucky if you have it.

    And she's using it during the minute we have it to try and make the difference in the lives of a lot of people.

    (END VIDEO CLIP)

    STUART VARNEY, GUEST HOST: A lot of people is right. Try 50 million people.

    Mitt Romney joining his wife, Ann, in Boston to launch her Center for Neurological Diseases, something very dear and near to Neil's heart.

    (BEGIN VIDEOTAPE)

    NEIL CAVUTO, HOST: Full disclosure here going into this interview: I am on the advisory board for the Ann Romney Center for Neurological Diseases.

    And did that not just because I personally like Ann Romney, but because I very much like and aspire to the cause that she's addressing, because regardless of your politics, as Ann and I discovered, this is a disease, and neurological ailments are those that target Republican and Democrats alike. They don't much care about your party affiliation, your social status, your wealth, whether you're in the media or being interviewed by the media.

    So, with that, let me begin with Ann Romney.

    Ann, welcome.

    ANN ROMNEY, WIFE OF MITT ROMNEY: Thank you.

    CAVUTO: This is a little different. And what intrigued me about this center is, it's not just an M.S. center. It's something bigger. Explain.

    A. ROMNEY: OK.

    Very excited about it, because this is going to be a different approach. We are going to be studying not just multiple sclerosis, but Alzheimer's, ALS, Parkinson's and brain tumors. So anything sort of related in the neuroscience area with the brain, we're putting a big -- a big umbrella around all of those disorders, putting it under one roof.

    It will be the Ann Romney Neurologic Center. And so we're -- we're excited about it. And what we hope will happen is a global sort of collision of collaboration that we're going to attempt to make with other researchers across this country and across the world that are studying these diseases.

    CAVUTO: You know what I have discovered? And you and I have chatted about this before, that a lot of these various research centers, whether it's for Alzheimer's or Parkinson's or ALS, they protect their research and fiefdoms very well.

    That's not to disparage them. But how are you going to encourage this, I don't know, charity comradery?

    (LAUGHTER)

    A. ROMNEY: Well, it's going to happen with -- we will hold conferences and symposiums.

    I think, generally, people in different fields hold those anyway. They hold scientific forums and they exchange papers. And you know that already goes on. But the fact we're broadening this to a much broader group is going to change that dynamic.

    I hope -- what I want is to be a catalyst. I want to explode this research, because we're on the cusp of so many breakthroughs. You know, it's so frustrating too look at aging parents that might have Alzheimer's and say, there's nothing we can do. That's about to change.

    CAVUTO: And there is this neurological link that people don't appreciate...

    A. ROMNEY: Yes.

    CAVUTO: ... and that a lot of this stuff, there's the technology to at least catch early, no known cure for pretty much any of these, but there are treatments that could stave off their progression.

    A. ROMNEY: There's -- as we know, there's treatments for M.S. There's no treatments at this point for Alzheimer's, for ALS, and there's some for Parkinson's, but limited. And brain tumors, again, they're -- they're spotty. And it's depending on the brain tumor.

    But it's a whole science of the brain coming together, researchers under one roof collaborating, finding discoveries, as when you interview the doctor, you will find out...

    CAVUTO: Right.

    A. ROMNEY: ... how they have already made some significant links in some of these research projects that they're doing.

    So for me, again, I just want to be a catalyst. I want -- I want to make a breakthrough. I want to accelerate the research.

    CAVUTO: But how tempted were you just because -- you mentioned treatments for M.S., but, again, no cures for M.S. So, people can look at this and say, Ann Romney, given her own experience with M.S., should focus on just that. And you say what?

    A. ROMNEY: Well -- well, I say it's -- it's broader than that, and that, you know, finding -- studying Alzheimer's is going to help study M.S. Studying Parkinson's is going to make breakthroughs in Lou Gehrig's.

    So, you know, we have to -- we have to start linking some of these molecules that are going on, on the brain and starred studying them, not just in one silo, but it's a broad -- as a broad spectrum.

    CAVUTO: I was noticing on the board for this that, does your husband know he's on that board that he's aware of?

    (LAUGHTER)

    A. ROMNEY: I am going to let him know.

    (LAUGHTER)

    CAVUTO: And -- and Congressman Joseph Kennedy?